From Compliance to Opportunity: How to Address the EU Device Regulation Changes

Posted by Matt Scheitlin on June 27, 2018

Likely, wherever you’re based in the world, you are aware of the General Data Protection Regulation (GDPR) that went into effect in Europe on May 25. These sweeping regulation changes affect every organization that controls or processes the personal data (whether customer or staff) of personnel based in the EU. If you’re reading this blog post, then your organization has been affected by the GDPR and, hopefully, built a capability over the past few years to ensure compliance. And if you’re best in class, your company is using the GDPR requirements as an opportunity to drive your business forward.


>
Read More

Marketing Excellence: An Overlooked Key to Launch Success

Posted by Matt Scheitlin on October 12, 2017

This is the second post in a two-part series on marketing excellence in the medtech industry. 

In my last post, I described an all-too-common scenario for many medtech companies: A lack of the marketing excellence needed to leverage the market, competitor and customer insights that drive business decisions. In this installment, I’ll describe how establishing a holistic and structured marketing approach helped one company on its journey toward global marketing excellence.


>
Read More

The Shift From Sales Excellence to Marketing Excellence

Posted by Matt Scheitlin on October 6, 2017

Ten years ago, having a sales force effectiveness center of excellence was unique in the medtech industry but is now a cornerstone of every high-performing organization. Now, marketing excellence is the next great differentiator for medtech commercial operations.


>
Read More

Populism in Healthcare: Listen to the Patient Before It's Too Late

Posted by Matt Scheitlin on December 9, 2016


Like many of you, I spent a lot of time this year thinking and discussing the state of our world. As an American living in London, it felt like there was no end to the information cycle. No matter where you fall on the political spectrum, 2016 was the year that it became apparent to the U.S. and the U.K. that the status quo was no longer an acceptable way forward for a significant portion of the population. Whether positive or negative in its outcome, people felt that the current way of political thinking (globalization, free trade, open borders, etc.) required a significant re-examination and, ultimately, a change.


>
Read More

In a Time of Change, Here’s What the U.S. Can Learn From Europe

Posted by Matt Scheitlin on August 11, 2016


Recently, I passed a milestone: In my professional career as a consultant, I have now spent more years working in Europe than I have in the U.S. When I was presented with the opportunity to move to Europe to support our growing medtech business, I quickly realized the unique opportunity and made the decision to move. Working with medtech firms across Europe as well as in the U.S. has given me a unique perspective on what works and what doesn’t from a commercial effectiveness standpoint.


>
Read More